Weidongli

Shenzhen Weidongli Biotechnology is a Chinese medical technology company specializing in the development, manufacturing, and distribution of in vitro diagnostic (IVD) products. The company focuses on point-of-care testing (POCT) solutions, including rapid diagnostic kits for infectious diseases, respiratory viruses, and chronic disease management. Their product portfolio features colloidal gold and fluorescence immunochromatography platforms, notably gaining international recognition for their COVID-19 antigen rapid test kits. Weidongli serves global markets, providing diagnostic tools to healthcare providers and laboratories. The company is committed to innovation in rapid testing to improve patient outcomes and public health monitoring.